2024-10-06 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**Company Overview:** CVS Health Corp is a healthcare company that operates pharmacy, drugstore, and health insurance businesses.

**1. Performance Comparison:**

* **Cumulative Return (CVS):** -31.14%
* **Cumulative Return (VOO):** 131.01%
* **Return Difference:** -162.15%
* **Relative Divergence:** 3.04% 

CVS has significantly underperformed the S&P 500 (VOO) over the period considered. Its relative divergence indicates it has underperformed in the past, but is currently performing slightly better than the average underperformance.

**2. Recent Price Action:**

* **Closing Price:** $62.92
* **5-Day Moving Average:** $62.27
* **20-Day Moving Average:** $58.88
* **60-Day Moving Average:** $58.66

CVS is trading above its 5, 20, and 60-day moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 72.83
* **PPO:** 0.94
* **Delta_Previous_Relative_Divergence:** -2.18
* **Expected Return:** 0.0%

The RSI indicates the stock is in overbought territory. The PPO suggests positive momentum. The negative delta_previous_relative_divergence signals a short-term downtrend. The expected return of 0.0% indicates potential limited growth, compared to the S&P 500, over the next 5 years.

**4. Recent Earnings:**

| Date       | EPS | Estimated EPS |
|------------|-----|---------------|
| 2024-08-07 | 1.83 | 1.73         |
| 2024-05-01 | 1.31 | 1.7          |
| 2024-02-07 | 2.12 | 2.01         |
| 2023-11-01 | 2.21 | 2.13         |
| 2023-08-02 | 2.21 | 2.12         |

The most recent earnings (2024-08-07) beat analysts' expectations. However, the previous earnings reports show mixed results, with some exceeding and others falling short of estimates.

**5. News and Recent Issues:**

* **Recent Market Outlook:** CVS is facing headwinds from rising inflation, a challenging economic environment, and competition from other pharmacy retailers.
* **Analyst Opinions:** Analysts have mixed opinions on CVS. Some believe the company's cost-cutting measures and focus on pharmacy services will drive future growth. Others are concerned about the impact of generic drug price pressure and potential healthcare reforms.
* **Performance Highlights:** CVS has been working on improving its operations and profitability. Its pharmacy services segment is growing, but its retail drugstore business is facing challenges.

**6. Conclusion:**

CVS is a large healthcare company with a solid market position. However, it faces challenges from the competitive retail environment, inflation, and healthcare reform. The stock has significantly underperformed the S&P 500 in the past, but is currently showing some signs of improvement. The technical indicators suggest a potential short-term downtrend, but the earnings results have been mixed. Investors should closely monitor CVS's earnings releases and its progress in addressing the challenges it faces.

**7. Investment Recommendation:**

Based on the current analysis, CVS may not be a strong investment opportunity at this time. The stock has underperformed the market and faces significant challenges. However, it could be a consideration for investors seeking exposure to the healthcare sector.

**Disclaimer:** This report is for informational purposes only and should not be considered investment advice. Always consult with a qualified financial professional before making any investment decisions.